Mechanically, SGLT2 inhibitors may exert beneficial effects on cancer initiation and progression through the regulation of crucial cancer hallmarks such as cellular growth, oxidative stress, and inflammatory responses. The gene discussed is SLC5A2; the disease is cancer.